STOCK TITAN

111 Financials

YI
FY2025 annual
Revenue $1.8B -9.0% YoY
Net Income -$3.2M -13.1% YoY
EPS (Diluted) -$0.05 0.0% YoY
Free Cash Flow $16.4M -51.7% YoY
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

111 (YI) reported $1.8B in revenue for fiscal year 2025, down 9.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI YI FY2025

A low-margin distribution model has reached operating breakeven, but shrinking sales and negative equity still define its financial mechanics.

Operating breakeven came through cost contraction, not stronger unit economics: sales contracted from $2.1B to $1.8B while gross margin stayed broadly flat, so the improvement reflects a smaller cost base rather than richer economics. By FY2025, SG&A had been compressed to $9.9M, while interest expense kept the bottom line negative.

Cash conversion improved materially: operating cash flow of $17.0M and free cash flow of $16.4M in FY2025 show near-breakeven operations translated into cash without heavy reinvestment. Inventory fell from $199.9M to $142.8M, consistent with working-capital release helping cash generation as sales slowed.

The balance sheet has little asset cushion: total liabilities of $415.0M exceed total assets of $314.6M, so obligations are not fully covered by recorded assets. A current ratio of 1.1x provides some near-term coverage, but equity of -$100.4M means there is no residual equity buffer for long-term creditors.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 21 / 100
Financial Health Score 21/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of 111's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
37

111 has an operating margin of 0.0%, meaning the company retains less than $1 of operating profit per $100 of revenue. This results in a moderate score of 37/100, indicating healthy but not exceptional operating efficiency. This is unchanged from the prior year.

Growth
13

111's revenue declined 9.0% year-over-year, from $2.0B to $1.8B. This contraction results in a growth score of 13/100.

Leverage
0

Not available for 111, and counted as zero in the overall score.

Liquidity
23

111's current ratio of 1.09 is below the typical benchmark, resulting in a score of 23/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
29

111's free cash flow margin of 0.9% results in a low score of 29/100. Capital expenditures of $636K absorb a large share of operating cash flow.

Returns
21
Altman Z-Score Safe
3.33

111 scores 3.33, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/7

111 passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed
N/A

111 reported a net loss of $3.2M while generating $17.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

111 reported an operating loss of $340K against $5.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.8B
YoY-9.0%
5Y CAGR+7.4%

111 generated $1.8B in revenue in fiscal year 2025. This represents a decrease of 9.0% from the prior year.

EBITDA
$1.4M
YoY-48.2%

111's EBITDA was $1.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 48.2% from the prior year.

Net Income
-$3.2M
YoY-13.1%

111 reported -$3.2M in net income in fiscal year 2025. This represents a decrease of 13.1% from the prior year.

EPS (Diluted)
-$0.05
YoY0.0%

111 earned -$0.05 per diluted share (EPS) in fiscal year 2025. That is unchanged from the prior year.

Cash & Balance Sheet

Free Cash Flow
$16.4M
YoY-51.7%

111 generated $16.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 51.7% from the prior year.

Cash & Debt
$73.1M
YoY+15.4%
5Y CAGR-16.7%

111 held $73.1M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Dividends Per Share

Not reported for fiscal year 2025.

Shares Outstanding

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
5.8%
YoY0.0pp

111's gross margin was 5.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. That is unchanged from the prior year.

Operating Margin
0.0%
YoY0.0pp
5Y CAGR+5.8pp

111's operating margin was 0.0% in fiscal year 2025, reflecting core business profitability. That is unchanged from the prior year.

Net Margin
-0.2%
YoY0.0pp
5Y CAGR+5.5pp

111's net profit margin was -0.2% in fiscal year 2025, showing the share of revenue converted to profit. That is unchanged from the prior year.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

Capital Expenditures
$636K
YoY-69.5%
5Y CAGR-30.5%

111 invested $636K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 69.5% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

YI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

YI annual income statement
MetricFY25FY24FY23FY22FY21FY20FY19FY18
Revenue$1.8B-9.0%$2.0B-6.3%$2.1B+7.4%$2.0B+0.5%$1.9B+55.1%$1.3B+121.5%$567.7M+118.5%$259.8M
Cost of Revenue$1.7B-9.0%$1.9B-6.4%$2.0B+8.0%$1.8B-0.8%$1.9BN/AN/AN/A
Gross Profit$103.4M-8.9%$113.6M-5.0%$119.6M-1.8%$121.8M+25.0%$97.5MN/AN/AN/A
SG&A Expenses$9.9M+2.3%$9.7M-69.2%$31.6M+5.9%$29.8M-8.2%$32.5M+65.3%$19.7M+10.8%$17.7M+23.5%$14.4M
Operating Income-$340K-217.6%$289K+100.6%-$49.3M+8.3%-$53.8M+46.6%-$100.8M-38.9%-$72.5M-2.3%-$70.9M-21.7%-$58.2M
Interest Expense$5.1M+31.1%$3.9M+36.8%$2.8M+45.6%$1.9M+126.4%$861K-36.3%$1.4M+159.8%$520KN/A
Income Tax$2K-84.6%$13K-62.9%$35K$0$0N/AN/A$1K
Net Income-$3.2M-13.1%-$2.8M+94.3%-$49.8M+8.7%-$54.5M+44.0%-$97.5M-36.1%-$71.6M+0.7%-$72.1M-29.7%-$55.6M
EPS (Diluted)-$0.050.0%-$0.05-$0.33+8.3%-$0.36+42.9%-$0.63N/AN/AN/A

Not reported in any period shown, so not listed: R&D Expenses.

YI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

YI annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18
Total Assets$314.6M-17.6%$381.9M-12.2%$435.1M-13.6%$503.7M+2.0%$493.6M+6.4%$463.8M+100.5%$231.3M+2.8%$224.9M
Current Assets$303.9M-16.3%$363.0M-12.1%$413.1M-11.9%$469.2M+6.7%$439.7M-0.1%$440.3M+106.9%$212.8M-2.9%$219.2M
Cash & Equivalents$73.1M+15.4%$63.3M-25.5%$85.0M-13.0%$97.7M-5.9%$103.8M-43.1%$182.3M+118.4%$83.5M-32.8%$124.2M
Inventory$142.8M-24.9%$190.1M-4.9%$199.9M-8.0%$217.3M+23.5%$175.9M+49.8%$117.5M+68.2%$69.8M+127.8%$30.7M
Accounts Receivable$37.1M-34.4%$56.6M-25.1%$75.6M+6.7%$70.9M+11.7%$63.5M+153.9%$25.0M+166.7%$9.4M+125.6%$4.2M
Total Liabilities$415.0M-11.7%$470.0M-9.1%$517.3M-8.2%$563.8M+8.2%$520.8M+27.3%$409.1M+240.5%$120.1M+156.0%$46.9M
Current Liabilities$279.4M-12.9%$320.9M-17.0%$386.6M-2.1%$395.1M+18.2%$334.2M+33.8%$249.8M+124.8%$111.1M+142.9%$45.7M
Total Equity-$100.4M-14.1%-$88.0M-7.1%-$82.2M-36.7%-$60.1M-121.0%-$27.2M-149.7%$54.8M-50.9%$111.6M-37.3%$178.1M
Retained Earnings-$564.9M-6.2%-$532.1M+1.1%-$537.9M-8.3%-$496.8M-5.2%-$472.3M-31.7%-$358.6M-32.6%-$270.5M-34.4%-$201.3M

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

YI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

YI annual cash flow statement
MetricFY25FY24FY23FY22FY21FY20FY19FY18
Operating Cash Flow$17.0M-52.7%$36.0M+157.2%-$63.0M-1777.0%-$3.4M+96.9%-$108.1M-504.0%-$17.9M+75.7%-$73.6M-47.5%-$49.9M
Capital Expenditures$636K-69.5%$2.1M+50.5%$1.4M-69.8%$4.6M-53.4%$9.8M+151.3%$3.9M+35.9%$2.9M+36.9%$2.1M
Free Cash Flow$16.4M-51.7%$34.0M+152.7%-$64.4M-711.4%-$7.9M+93.3%-$117.9M-440.7%-$21.8M+71.5%-$76.5M-47.1%-$52.0M
Investing Cash Flow-$7.7M-250.0%$5.1M-76.0%$21.4M+412.5%-$6.8M-172.5%$9.4M+119.0%-$49.8M-245.7%$34.1M+428.0%$6.5M
Financing Cash Flow-$3.0M+94.6%-$55.7M-291.8%$29.0M+780.2%$3.3M-71.7%$11.7M-92.9%$164.0M+947.9%$15.7M-88.9%$141.5M
Share BuybacksN/AN/AN/AN/A$924K-49.7%$1.8M-44.4%$3.3MN/A

Not reported in any period shown, so not listed: Dividends Paid.

YI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

YI annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18
Gross Margin5.8%0.0pp5.8%+0.1pp5.7%-0.5pp6.2%+1.2pp5.0%N/AN/AN/A
Operating Margin0.0%0.0pp0.0%+2.4pp-2.3%+0.4pp-2.7%+2.4pp-5.2%+0.6pp-5.8%+6.7pp-12.5%+9.9pp-22.4%
Net Margin-0.2%0.0pp-0.1%+2.2pp-2.4%+0.4pp-2.8%+2.2pp-5.0%+0.7pp-5.7%+7.0pp-12.7%+8.7pp-21.4%
Return on EquityN/AN/AN/AN/AN/A-130.7%-66.1pp-64.6%-33.4pp-31.2%
Return on Assets-1.0%-0.3pp-0.8%+10.7pp-11.4%-0.6pp-10.8%+8.9pp-19.7%-4.3pp-15.4%+15.7pp-31.2%-6.5pp-24.7%
Current Ratio1.090.0x1.13+0.1x1.07-0.1x1.19-0.1x1.32-0.4x1.76-0.2x1.92-2.9x4.79
Debt-to-EquityN/AN/AN/AN/AN/A7.47+6.4x1.08+0.8x0.26
FCF Margin0.9%-0.8pp1.7%+4.8pp-3.1%-2.7pp-0.4%+5.6pp-6.0%-4.3pp-1.7%+11.7pp-13.5%+6.6pp-20.0%

Note: Shareholder equity is negative (-$100.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

What is 111's annual revenue?

111 (YI) reported $1.8B in total revenue for fiscal year 2025. This represents a -9.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is 111's revenue growing?

111 (YI) revenue declined by 9.0% year-over-year, from $2.0B to $1.8B in fiscal year 2025.

Is 111 profitable?

No, 111 (YI) reported a net income of -$3.2M in fiscal year 2025, with a net profit margin of -0.2%.

111 (YI) reported diluted earnings per share of -$0.05 for fiscal year 2025. That is unchanged from the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

111 (YI) had EBITDA of $1.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

111 (YI) had a gross margin of 5.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

111 (YI) had an operating margin of 0.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

111 (YI) had a net profit margin of -0.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

111 (YI) generated $16.4M in free cash flow during fiscal year 2025. This represents a -51.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

111 (YI) generated $17.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

111 (YI) had $314.6M in total assets as of fiscal year 2025, including both current and long-term assets.

111 (YI) invested $636K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

111 (YI) had a current ratio of 1.09 as of fiscal year 2025, which is considered adequate.

111 (YI) had a return on assets of -1.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

111 (YI) has negative shareholder equity of -$100.4M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

111 (YI) has an Altman Z-Score of 3.33, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

111 (YI) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

111 (YI) reported a net loss of $3.2M while generating $17.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

111 (YI) reported an operating loss of $340K against $5.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

111 (YI) scores 21 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top